Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Management of myasthenia gravis during pregnancy: A report of eight cases

Management of myasthenia gravis during pregnancy: A report of eight cases AbstractBackgroundThe clinical course of myasthenia gravis (MG) during pregnancy is highly variable and unpredictable. The management of MG in pregnancy has not been standardized.MethodsEight cases of MG in pregnancy, who were treated and gave birth in our hospital between 2004 and 2012, were retrospectively reviewed.ResultsIn three patients, MG deteriorated during pregnancy. Three patients discontinued their medication for MG during their pregnancy, and the other five patients continued on corticosteroid or pyridostigmine. None of the infants showed any congenital abnormalities. Interestingly, there was a trend towards lower birth weight in infants born to women who had an exacerbation of MG during pregnancy. One patient who had unstable MG before pregnancy and voluntarily discontinued the medication for MG at the beginning of pregnancy, experienced MG exacerbation at the 30th week of pregnancy and gave birth prematurely to an infant with transient neonatal MG at the 34th week. The other seven patients had uneventful full-term pregnancy.ConclusionWomen with unstable MG should postpone pregnancy to avoid potential risk of MG exacerbation and adverse effects on the fetus. Medication for MG should not be stopped abruptly during pregnancy, particularly for women with unstable MG. MG during pregnancy should be closely monitored and properly controlled. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Open Life Sciences de Gruyter

Management of myasthenia gravis during pregnancy: A report of eight cases

Shi, Beibei; Zeng, Linchai
Open Life Sciences , Volume 13 (1): 6 – Apr 6, 2018
Download PDF
6 pages

Loading next page...
 
/lp/degruyter/management-of-myasthenia-gravis-during-pregnancy-a-report-of-eight-Fkk8HL0SE2

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
de Gruyter
Copyright
© 2018 Beibei Shi, Linchai Zeng
ISSN
2391-5412
eISSN
2391-5412
DOI
10.1515/biol-2018-0004
Publisher site
See Article on Publisher Site

Abstract

AbstractBackgroundThe clinical course of myasthenia gravis (MG) during pregnancy is highly variable and unpredictable. The management of MG in pregnancy has not been standardized.MethodsEight cases of MG in pregnancy, who were treated and gave birth in our hospital between 2004 and 2012, were retrospectively reviewed.ResultsIn three patients, MG deteriorated during pregnancy. Three patients discontinued their medication for MG during their pregnancy, and the other five patients continued on corticosteroid or pyridostigmine. None of the infants showed any congenital abnormalities. Interestingly, there was a trend towards lower birth weight in infants born to women who had an exacerbation of MG during pregnancy. One patient who had unstable MG before pregnancy and voluntarily discontinued the medication for MG at the beginning of pregnancy, experienced MG exacerbation at the 30th week of pregnancy and gave birth prematurely to an infant with transient neonatal MG at the 34th week. The other seven patients had uneventful full-term pregnancy.ConclusionWomen with unstable MG should postpone pregnancy to avoid potential risk of MG exacerbation and adverse effects on the fetus. Medication for MG should not be stopped abruptly during pregnancy, particularly for women with unstable MG. MG during pregnancy should be closely monitored and properly controlled.

Journal

Open Life Sciences – de Gruyter

Published: Apr 6, 2018

References

  • Myasthenia gravis in pregnancy
  • The management of myasthenia gravis in pregnancy
  • International consensus guidance for management of myasthenia gravis: Executive summary
  • Management of pregnancy with myasthenia gravis: 7 cases report
  • Course and treatment of myasthenia gravis during pregnancy
  • Myasthenia gravis consequences for pregnancy, delivery and the newborn
  • Myasthenia gravis and pregnancy: report of 13 cases
  • Gravis Clinical management issues before during and after pregnancy
    Hassan
  • Myasthenia gravis and pregnancy: clinical implications and neonatal outcome
  • Myasthenia gravis: management issues during pregnancy
  • Myasthenia gravis and pregnancy case report
  • Myasthenia gravis
  • Immunologic diseases in pregnancy
  • Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care
  • Corticosteroid during pregnancy and oral clefts: a case-control study
  • Transient neonatal myasthenia gravis revealing a myasthenia gravis and a systemic lupus erythematosus in the mother: case report and review of the literature
  • Effect of pregnancy and birth on the course of myasthenia gravis before or after transsternal radical thymectomy
  • Pregnancy in myasthenia gravis and neonatal myasthenia gravis
  • Factors associated with fetal losses in severe systemic lupus erythematosus
  • Myasthenia gravis and pregnancy
  • No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study
  • Myasthenia gravis during pregnancy
  • Myasthenia gravis in pregnancy: report on 69 cases
  • Myasthenia gravis during pregnancy
  • Myasthenia gravis